Allion Healthcare acquires Biomed
Allion has acquired Biomed for $48 million in cash, 9.35 million shares of Allion common and series A-1 preferred stock and the assumption of $18.6 million of Biomed
BeOne Medicines is set to invest $300m in expanding its manufacturing and research operations at the Princeton West Innovation Campus in Hopewell, New Jersey, US.